Educational moderation of gender disparities in psychedelic health outcomes
S. Viña
Academia Mental Health and Well-Being March 6, 2025 DOI: 10.20935/mhealthwellb7580 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study using pooled cross-sectional survey data Peer reviewed |
|---|---|
| Sample size | 458,372 |
| Population | Respondents to the National Survey of Drug Use and Health (NSDUH), 2008-2019 |
| Keywords | Education |
| Key findings | Lifetime classic psychedelic use was associated with higher psychological distress overall, but this association varied by education level in three-way interaction models. The authors argue that the mental health correlates of psychedelic use depend on social factors such as education and gender rather than being uniformly beneficial. |
Abstract
While public interest in psychedelics is rising due to their potential effects on mental health, evidence suggests that these associations vary across demographic groups. Notably, prior research indicates that women may experience different outcomes from psychedelic use compared to men. Given that highly educated women tend to have superior health outcomes in general, this study examines whether education modifies the association between Lifetime Classic Psychedelic Use (LCPU) and psychological distress. Using pooled data from the National Survey of Drug Use and Health (NSDUH) (2008–2019) (n = 458,372), this study applies nested Ordinary Least Square Regression (OLS) regression models in Stata 18. Results from three-way interaction terms indicate that while LCPU is associated with higher distress overall, the association varies across education levels. This pattern suggests that rather than universally improving mental health, the effects of psychedelic use depend on key social factors such as education and gender.
Citations in the library
Cited by 6
- The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress Healthcare May 16, 2025
- How to set up a psychedelic study: Unique considerations for research involving human participants. Neuroscience & Biobehavioral Reviews July 1, 2026
- Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians Psychoactives September 4, 2025
- Can Education Compensate for Poor Healthcare? Racial Inequalities in Psychedelic-Associated Psychological Distress Research Square January 14, 2026
- From Science to Pleasure: Justifications of the Use of Classic Psychedelics in Finland. Nordisk Alkohol Nark December 30, 2025
and 1 more in the library
Cites 51
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
and 46 more in the library